Literature DB >> 33430618

Minireview: Insights into anti-interferon-γ autoantibodies.

Kriangkrai Chawansuntati1, Kritsadee Rattanathammethee1, Jiraprapa Wipasa1.   

Abstract

The association between the presence of anti-interferon-γ autoantibodies and the onset of immunodeficiency with intracellular infections has been clearly established. No standard regimen to control the production of these pathogenic autoantibodies, apart from antimicrobial therapy to eliminate infections, contributes to the medical burden of this syndrome, which sometimes has a fatal outcome. In this review, we summarize the findings on anti-interferon-γ autoantibodies to facilitate further research and to provide guidance for treatment strategies.

Entities:  

Keywords:  Immune deficiency; adult-onset immunodeficiency; anti-interferon-γ antibodies; intracellular organism infection

Mesh:

Substances:

Year:  2021        PMID: 33430618      PMCID: PMC8719035          DOI: 10.1177/1535370220981579

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  61 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.

Authors:  Hiroki Furuya; Kei Ikeda; Kazusa Miyachi; Kaito Nakamura; Kazumasa Suzuki; Shunsuke Furuta; Tomohiro Tamachi; Koichi Hirose; Takuro Sakagami; Hiroshi Nakajima
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

3.  Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms.

Authors:  Jiraprapa Wipasa; Romanee Chaiwarith; Kriangkrai Chawansuntati; Jutarat Praparattanapan; Kritsadee Rattanathammethee; Khuanchai Supparatpinyo
Journal:  Exp Biol Med (Maywood)       Date:  2018-03-07

4.  Natural antibodies to IFN-gamma in man and their increase during viral infection.

Authors:  A Caruso; C Bonfanti; D Colombrita; M De Francesco; C De Rango; I Foresti; F Gargiulo; R Gonzales; G Gribaudo; S Landolfo
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

5.  Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.

Authors:  Kazutaka Yoshizawa; Ami Aoki; Kenjiro Shima; Yoshinari Tanabe; Toshiyuki Koya; Takashi Hasegawa; Toshiaki Kikuchi; Takuro Sakagami
Journal:  J Clin Immunol       Date:  2020-02-07       Impact factor: 8.317

6.  The level of natural autoantibodies to IFN-gamma in varicella infection treated with antiviral drug Anaferon for children: A pilot study.

Authors:  Elena Don; Nathalie van der Meide; Valery Egorov; Mikhail Putilovskiy; Sergey Tarasov
Journal:  Immunol Lett       Date:  2019-12-12       Impact factor: 3.685

Review 7.  Gene modulation and immunoregulatory roles of interferon gamma.

Authors:  Banishree Saha; S Jyothi Prasanna; Bhagawat Chandrasekar; Dipankar Nandi
Journal:  Cytokine       Date:  2009-12-29       Impact factor: 3.861

8.  First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies.

Authors:  H Namkoong; T Asakura; M Ishii; S Yoda; K Masaki; T Sakagami; E Iwasaki; Y Yamagishi; T Kanai; T Betsuyaku; N Hasegawa
Journal:  New Microbes New Infect       Date:  2018-10-19

9.  Disseminated Mycobacterium szulgai infection in a patient with anti-interferon-gamma autoantibodies.

Authors:  Tzu-Ping Weng; Ling-Shan Syue; Nan-Yao Lee
Journal:  IDCases       Date:  2020-05-28

10.  Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA.

Authors:  Arnone Nithichanon; Ploenchan Chetchotisakd; Takayuki Matsumura; Yoshimasa Takahashi; Manabu Ato; Takuro Sakagami; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

View more
  4 in total

1.  Sweet's Syndrome Accompanied by Coinfection with Multiple Pathogens and Disseminated Mycobacterium phlei Infection Presenting with Osteolytic Destruction During 12 Years of Follow-Up: A Rare Case Report.

Authors:  Mengxin Tang; Mianluan Pan; Ye Qiu; Jie Huang; Wen Zeng; Jianquan Zhang
Journal:  Infect Drug Resist       Date:  2022-05-10       Impact factor: 4.177

Review 2.  Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

Authors:  Aristine Cheng; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2022-01       Impact factor: 14.290

Review 3.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

4.  Periocular Infection of Mycobacterium avium Complex in a Patient with Interferon-γ Autoantibodies: A Case Report.

Authors:  Tzu-Hui Lo; Tou-Yuan Tsai; Lih-Shinn Wang; Tzu-Lun Huang; Nancy Chen
Journal:  Medicina (Kaunas)       Date:  2022-06-24       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.